New horizons: Antiretroviral therapy in 1997

Journal of the Association of Nurses in AIDS Care

Volumn 8, Issue 4, 1997, Pages 26-38

  Williams, Ann B ^a  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Antiretroviral therapy; Combination therapy; Drug resistance

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIBIOTIC RESISTANCE; DECISION MAKING; DRUG COMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; METHODOLOGY; PATIENT PARTICIPATION; REVIEW;

ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; DECISION MAKING; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; PATIENT PARTICIPATION; PROFESSIONAL-PATIENT RELATIONS; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0031181234     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3290(97)80011-8     Document Type: Article

References (2)

1. Abbott Laboratories. (1996). NORVIR prescribing information. North Chicago, IL: Abbott Laboratories.
2. Carpenter, C.C.J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J.S.G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., & Volberding, P. A. (1996). Antiretroviral therapy for HIV infection in 1996. Journal of the American Medical Association, 276(2), 146-154.